International | HealthTech Investment
Investing in what's next.
Validating what matters.
We are building a clinically integrated HealthTech investment platform that connects capital, clinical expertise and commercialisation to help promising innovation reach real-world care internationally.
Capital alone is not enough.
A promising technology is only the beginning. The path to routine care also depends on clinical effectiveness, workflow fit, adoption, economic viability and a route to market. CHP is being built to connect these disciplines within one investment approach.
The model
Four capabilities. One connected model.
- 01
Capital
Disciplined, staged investment aligned with evidence and opportunity.
- 02
Clinical validation
Physician-led assessment, real-world pilots and outcome measurement.
- 03
Commercialisation
Licensing, integration, distribution and strategic partnerships.
- 04
International deployment
A focus on credible pathways across international markets, informed by global innovation.
Our process
A pathway from discovery to adoption.
Five stages that connect sourcing with evidence, adoption and commercialisation.
- 01IdentifySource innovation globally and screen technologies, devices and platforms against healthcare needs and strategic fit.
- 02EvaluateBring together clinical expert review, scientific assessment and market attractiveness.
- 03ValidateUse appropriately governed clinical pilots, workflow assessment and outcome measurement to build evidence.
- 04ImplementAssess live integration, adoption and economic viability in relevant care settings.
- 05CommercialiseDevelop routes to regional deployment, licensing and strategic partnerships.
Investment focus
Focused on the technologies shaping better care.
AI and digital innovation can enable progress across all six themes, rather than forming a theme of their own.
Cardiometabolic Health
Technologies supporting the prevention, detection and management of cardiometabolic conditions, evaluated for their clinical relevance and practical adoption.
Explore this themeLongevity & Healthy Ageing
Evidence-led approaches to understanding health trajectories and supporting healthier lives as people age.
Explore this themeWomen's Health
Innovation addressing women's healthcare needs across fertility, pregnancy and hormonal health, with attention to evidence, usability and continuity of care.
Explore this themePrecision Medicine
Technologies that help translate more detailed clinical and biological information into better-informed diagnostic and treatment decisions.
Explore this themeCare Delivery Transformation
Tools and services designed to improve how care is organised, delivered and supported, within facilities and beyond them.
Explore this themeMedTech & Devices
Medical technologies with a clear intended use, a credible evidence pathway and practical relevance to healthcare delivery.
Explore this theme
Founding team
Built on complementary experience.
Zaid Al Siksek
Co-founder & Chairman
Healthcare investment, operating platforms and regional healthcare leadership.
Dr. Mohammad Yaqub
Co-founder & Chief Technology Officer
AI in healthcare, medical-technology translation and venture building.
Naser Al Rashdi
Co-founder | Strategy, Governance & Partnerships
Strategy, policy, investment and institutional partnerships.
Geography
Global innovation. Regional relevance.
Our strategy connects innovation, clinical expertise and commercial opportunity across international markets.
International deployment focus
- Europe
- North America
- Asia-Pacific
Partnership reach
- Healthcare systems
- Research networks
- Strategic partners
These are areas of investment interest and sourcing focus. They do not represent offices, licences or a completed portfolio footprint.
Move healthcare innovation forward.
Global innovation. Regional relevance. Real-world impact.